Financhill
Sell
42

CLB Quote, Financials, Valuation and Earnings

Last price:
$11.88
Seasonality move :
-0.63%
Day range:
$11.63 - $11.98
52-week range:
$10.14 - $25.13
Dividend yield:
0.34%
P/E ratio:
20.08x
P/S ratio:
1.09x
P/B ratio:
2.19x
Volume:
298.4K
Avg. volume:
632.5K
1-year change:
-33.8%
Market cap:
$555.6M
Revenue:
$523.8M
EPS (TTM):
$0.59

Analysts' Opinion

  • Consensus Rating
    Core Laboratories has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $15.80, Core Laboratories has an estimated upside of 33.33% from its current price of $11.85.
  • Price Target Downside
    According to analysts, the lowest downside price target is $11.00 representing 100% downside risk from its current price of $11.85.

Fair Value

  • According to the consensus of 3 analysts, Core Laboratories has 33.33% upside to fair value with a price target of $15.80 per share.

CLB vs. S&P 500

  • Over the past 5 trading days, Core Laboratories has underperformed the S&P 500 by -3.05% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Core Laboratories does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Core Laboratories revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Core Laboratories reported revenues of $123.6M.

Earnings Growth

  • Core Laboratories earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Core Laboratories reported earnings per share of --.
Enterprise value:
663.8M
EV / Invested capital:
1.73x
Price / LTM sales:
1.09x
EV / EBIT:
12.20x
EV / Revenue:
1.28x
PEG ratio (5yr expected):
0.36x
EV / Free cash flow:
15.10x
Price / Operating cash flow:
12.80x
Enterprise value / EBITDA:
9.59x
Gross Profit (TTM):
$87.6M
Return On Assets:
4.72%
Net Income Margin (TTM):
5.41%
Return On Equity:
11.15%
Return On Invested Capital:
7.17%
Operating Margin:
5.69%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $502.8M $511.1M $517.8M $129.6M $123.6M
Gross Profit $87.9M $92.5M $87.6M $21.2M $20.4M
Operating Income $46.7M $57.8M $46.8M $9.7M $7M
EBITDA $65M $72.3M $69.2M $12.4M $8.1M
Diluted EPS $0.50 $0.78 $0.59 $0.07 --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $185.8M $202.2M $227.9M $229M $228.8M
Total Assets $584.4M $584.9M $593.6M $588M $591.5M
Current Liabilities $85.5M $99.8M $95.6M $85.5M $103.7M
Total Liabilities $438.4M $418.5M $393.5M $350.5M $332.2M
Total Equity $146M $166.4M $200.2M $237.4M $259.4M
Total Debt $208.2M $189.8M $180.4M $160.4M $124.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations $16.5M $33.5M $57.5M $5.5M $6.7M
Cash From Investing -$6.3M -$6.3M -$4M -$1.7M $772K
Cash From Financing -$15.9M -$28.6M -$46.4M -$4.1M -$4.5M
Free Cash Flow $6.4M $22.1M $44M $2.5M $3.1M
CLB
Sector
Market Cap
$555.6M
$61.5M
Price % of 52-Week High
47.16%
60.2%
Dividend Yield
0.34%
0%
Shareholder Yield
2.42%
4.8%
1-Year Price Total Return
-33.8%
-29.17%
Beta (5-Year)
1.446
0.677
Dividend yield:
0.34%
Annualized payout:
$0.04
Payout ratio:
6.7%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $11.84
200-day SMA
Sell
Level $17.41
Bollinger Bands (100)
Sell
Level 12.64 - 17.94
Chaikin Money Flow
Buy
Level 105.7K
20-day SMA
Sell
Level $11.86
Relative Strength Index (RSI14)
Sell
Level 45.77
ADX Line
Sell
Level 25.07
Williams %R
Neutral
Level -47.4026
50-day SMA
Sell
Level $13.16
MACD (12, 26)
Buy
Level 0.34
25-day Aroon Oscillator
Sell
Level -16
On Balance Volume
Sell
Level -5.3M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.2951)
Buy
CA Score (Annual)
Level (-0.1023)
Buy
Beneish M-Score (Annual)
Level (-2.5557)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.6052)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.

Stock Forecast FAQ

In the current month, CLB has received 0 Buy ratings 3 Hold ratings, and 0 Sell ratings. The CLB average analyst price target in the past 3 months is $15.80.

  • Where Will Core Laboratories Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Core Laboratories share price will rise to $15.80 per share over the next 12 months.

  • What Do Analysts Say About Core Laboratories?

    Analysts are divided on their view about Core Laboratories share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Core Laboratories is a Sell and believe this share price will drop from its current level to $11.00.

  • What Is Core Laboratories's Price Target?

    The price target for Core Laboratories over the next 1-year time period is forecast to be $15.80 according to 3 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is CLB A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Core Laboratories is a Hold. 3 of 3 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of CLB?

    You can purchase shares of Core Laboratories via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Core Laboratories shares.

  • What Is The Core Laboratories Share Price Today?

    Core Laboratories was last trading at $11.88 per share. This represents the most recent stock quote for Core Laboratories. Yesterday, Core Laboratories closed at $11.85 per share.

  • How To Buy Core Laboratories Stock Online?

    In order to purchase Core Laboratories stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Unity Software a Buy Now?
Is Unity Software a Buy Now?

Unity Software (NYSE:U) is the company behind the popular Unity…

Will Uber Stock 5X?
Will Uber Stock 5X?

Uber (NYSE:UBER) has generated extremely strong returns for its investors…

How High Will Bloom Energy Stock Go?
How High Will Bloom Energy Stock Go?

Bloom Energy (NYSE:BE) has seen its shares surge by more…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Sell
25
GLOB alert for May 17

Globant SA [GLOB] is down 23.54% over the past day.

Buy
62
VEON alert for May 17

VEON [VEON] is down 0.31% over the past day.

Sell
15
UNH alert for May 17

UnitedHealth Group [UNH] is up 6.39% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock